Market cap
$0 Mln
Recently Viewed
Clear All$0.00
$0.00 (0.00%)As on 01-May-2026 09:30EDT
Market cap
$0 Mln
Revenue (TTM)
$14 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
-0.8 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
-1.6
Debt to Equity
0.3
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
19,730,247
CFO
$-15.57 Mln
EBITDA
$-42.82 Mln
Net Profit
$-82.97 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Novo Integrated Sciences (NVOS)
| 14.8 | 416.7 | 520.0 | -- | -86.3 | -83.6 | -55.9 |
|
BSE Sensex*
| -9.2 | 6.9 | -6.5 | -4.2 | 8.0 | 9.1 | 11.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
Novo Integrated Sciences (NVOS)
| -59.2 | -85.6 | -66.7 | -6.6 | -77.5 | 283.3 | 115.4 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Novo Integrated Sciences (NVOS)
|
0.0 | 0.1 | 13.3 | -16.1 | -115.3 | -81.2 | -- | 0.0 |
| 14.3 | 3,405.6 | 3,125.0 | -262.7 | 0.9 | -313.2 | -- | 20.5 | |
| 422.2 | 5,603.8 | 2,540.6 | 259.8 | 13.7 | 27 | 23 | 6.7 | |
| 107.5 | 10,685.3 | 6,066.4 | 609.2 | 17.9 | 16.2 | 19.4 | 4.1 | |
| 27.4 | 6,416.5 | 2,347.6 | 128.4 | 4.5 | 25.2 | 55.2 | 11.9 | |
| 20.0 | 4,203.8 | 5,649.5 | 207.6 | 7.0 | 15.2 | 21.2 | 3.3 | |
| 56.9 | 4,374.6 | 2,040.2 | -18.7 | 5.0 | -1.9 | -- | 4.2 | |
| 15.5 | 4,405.7 | 1,163.6 | 78.0 | 26.1 | 15.4 | 57.2 | 7.3 | |
| 183.3 | 16,056.0 | 21,455.0 | 1,703.0 | 16.4 | 17.1 | 9.5 | 3.2 | |
| 183.7 | 10,888.4 | 5,057.8 | 344.0 | 9.2 | 16.9 | 31.9 | 4.9 |
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers... physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health programs, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning programs, including event and game coverage, and private personal training services through clinics. It also provides assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services through long-term care homes, retirement homes, community-based home care physiotherapy, community-based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement homes and community, and long-term care sectors. Further, it provides medical technology platforms, such as Novo Connect, telemedicine/telehealth, and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company was formerly known as Turbine Truck Engines, Inc. and changed its name to Nova Integrated Sciences, Inc. in July 2017. The company is headquartered in Bellevue, Washington. Address: 11120 NE 2nd Street, Bellevue, WA, United States, 98004 Read more
Chairman of the Board & CEO
Mr. Robert Mattacchione
Chairman of the Board & CEO
Mr. Robert Mattacchione
Headquarters
Bellevue, WA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Novo Integrated Sciences Inc (NVOS) is $0.00 (NASDAQ) as of 01-May-2026 09:30 EDT. Novo Integrated Sciences Inc (NVOS) has given a return of -86.28% in the last 3 years.
Since, TTM earnings of Novo Integrated Sciences Inc (NVOS) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
The 52-week high and low of Novo Integrated Sciences Inc (NVOS) are Rs 0.06 and Rs 0.00 as of 02-May-2026.
Novo Integrated Sciences Inc (NVOS) has a market capitalisation of $ 0 Mln as on 29-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Novo Integrated Sciences Inc (NVOS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.